Last reviewed · How we verify
NCT07245862: S-FAME
Evaluation of a Family-centered Program for Problematic Gaming/Excessive Screen Use
NA trial testing Family-centered Program for Problematic Gaming/Excessive Screen Use in a child and adolescent population within Social Services in Adolescent Behavior in 170 participants. Not yet recruiting.
1 January 2027
Quick facts
| Lead sponsor | Region Skane |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 170 |
| Start date | 1 January 2026 |
| Primary completion | 1 January 2027 |
| Estimated completion | 1 January 2028 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Family-centered Program for Problematic Gaming/Excessive Screen Use in a child and adolescent population within Social Services
- Control
Conditions studied
- Adolescent Behavior — all drugs for Adolescent Behavior →
- Social Media Addiction — all drugs for Social Media Addiction →
- Gaming Disorder — all drugs for Gaming Disorder →
- Family Relations — all drugs for Family Relations →
Sponsor
Region Skane — full company profile →
Who can join
Adults 11 to 14, any sex, with Adolescent Behavior or Social Media Addiction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Family-Centered Program for Problematic Gaming and Excessive Screen Use (FAME) is a pioneering initiative designed to address the growing challenges of excessive screen use and gaming among children and adolescents, particularly within family dynamics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07245862
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adolescent Behavior
Currently open trials in the same condition.
- NCT07427329 — Benefits of Physical Activity During the School Day to Reduce Mental Fatigue and Optimize Cognitive and Psychosocial Pro · NA · active not recruiting
- NCT07029919 — Personalized Approach To Habits - Sleep · NA · recruiting
- NCT06894277 — Internet-based Talking About Risk and Adolescent Choices: Health and Emotion Regulation Options · NA · recruiting
- NCT06576076 — Cannabis, Linked Emotions, and Adolescent Risk Study · NA · recruiting
- NCT06670066 — Rigorous Evaluation of Let's Talk Birth Control · NA · recruiting
Other Region Skane trials
Trials by the same sponsor.
- NCT07511673 — The Study is a Randomised Clinical Trial (RCT) to Test if Preoperative Dental Screening is Superior to no Preoperative D · NA · not yet recruiting
- NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
- NCT07494669 — Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery · not yet recruiting
- NCT07462351 — System-integrated Point-of-Care Ultrasound in Breast Cancer Screening · NA · recruiting
- NCT06975696 — Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07245862 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Region Skane
- Last refreshed: 24 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07245862.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing